Completed OBSERVATIONAL NCT04568421

Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection (SAR-COVID)

Sponsor: Sociedad Argentina de Reumatologia

Updated 7 times since 2020 Last updated: Jan 30, 2023 Started: Aug 18, 2020 Primary completion: Dec 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Rheumatic Diseases and is currently completed. Sociedad Argentina de Reumatologia leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2023 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Oct 2022 — Mar 2023 [monthly]

Unknown Status

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jan 2021 — Oct 2022 [monthly]

Recruiting
Oct 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sociedad Argentina de Reumatologia

Data source: Sociedad Argentina de Reumatologia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Buenos Aires, Argentina